V. Kalaiselvan
Indian Pharmacopoeia Commission,
Government of India (Ministry of Health & Family Welfare), INDIA
Abstract
The Materiovigilance programme of India (MvPI), launched by the Ministry of Health & Family Welfare, Government of India; the Indian Pharmacopoeia Commission (IPC)mandated with the responsibilities to coordinate as National Coordination Centre (NCC). The MvPI aims to collect, collate and analyze the adverse events associated with the use of medical devices and communicate the safety outcomes to healthcare professionals and Central Drugs Standard Control Organization (CDSCO). The IPC as NCC plays a crucial role in establishing the programme by recognizing Medical Devices Adverse Events monitoring centres (as a dynamic process), providing training to the stakeholders, effectively coordinating with CDSCO and state drug control authorities for effective implementation of MvPI. The culture of suspected adverse events of medical devices reporting among the healthcare providers in India is increasing year by year. The reported adverse events are regularly analyzed and findings have been communicated to the stakeholders. The IPC is committed to promote the MvPI starting from primary health care. Also IPC is working towards establishing a network of academic and research institutes as well to understand the devices related issues through research based approach.
How to cite this paper